Current Studies
Study in Major Depressive Disorder With BTRX-335140 vs Placebo
GAIN Trial: Phase 2/3 Study of COR388 in Subjects With Alzheimer's Disease
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate STS101 in the Acute Treatment of Migraine (EMERGE)
A Study to Evaluate SAGE-217 in Adult Subjects With Major Depressive Disorder
FreeStyle Libre Flash Glucose Monitoring System Post Approval Study for Pediatric Patients
- For participants ages 25 to 65
- Have Major Depressive Disorder with decreased ability to enjoy usual activities.
GAIN Trial: Phase 2/3 Study of COR388 in Subjects With Alzheimer's Disease
- For participants ages 55 to 80
- Have Mild to Moderate Alzheimer's Disease
- Have a Study Partner or Caregiver who can attend study visit
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate STS101 in the Acute Treatment of Migraine (EMERGE)
- Participants ages 18 to 65
- Experience between 2 and 8 migraines per month
A Study to Evaluate SAGE-217 in Adult Subjects With Major Depressive Disorder
- Are 18 - 75 years of age
- Have had symptoms of Major Depression for at least 4 weeks
- This study involves taking a study medication for 2 weeks and then follow up for 12 months.
FreeStyle Libre Flash Glucose Monitoring System Post Approval Study for Pediatric Patients
- Are 11- 17 years of age
- Have been diagnoses with Type I or Type II diabetes
- This is a study of a blood glucose monitoring device